CompoAtlas

CELFULL T-turn D

Natural health product licensed in Canada

Licence holder
CELFULL BIO-TECH (USA) INC.
NPN or DIN-HM
80121312
Status
Active licence
Licence date
27 September 2022
Revision date
Not provided
Form
Capsule, dur
Route of administration
Orale
Application type
Générale (non traditionelle)

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Nattokinase

Source : Bacillus subtilis var. natto - Whole

100 mgNot calculated
Monascus purpurea-fermented Oryza sativa

Source : Espèces de levure de riz rouge - Entiere

125 mgNot calculated
Huile de poisson

Source : Engraulidae - en entier

Potency : 3.3 mg Docosahexaenoic acid

67 mgNot calculated
Huile de poisson

Source : Engraulidae - en entier

Potency : 17 mg Eicosapentaenoic acid

Not specifiedNot calculated

Non-medicinal ingredients

Dioxyde de silicium, Poudre de racine de Zingiber Officinale (Gingembre), bêta-D-glucane, Gélatine

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 day

Uses authorised in Canada

Text supplied in English because no French text is available.

Helps support cardiovascular system health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80121312

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line